NDC 72934-4023

BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5%

Betamethasone Dipropionate 0.05% / Minoxidil 5%

BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Minoxidil; Betamethasone Dipropionate.

Product ID72934-4023_8747c1ea-6b25-46c8-e053-2995a90a33df
NDC72934-4023
Product TypeHuman Prescription Drug
Proprietary NameBETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5%
Generic NameBetamethasone Dipropionate 0.05% / Minoxidil 5%
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date2019-05-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameMINOXIDIL; BETAMETHASONE DIPROPIONATE
Active Ingredient Strength5 g/100g; g/100g
Pharm ClassesArteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-4023-8

60 g in 1 BOTTLE, GLASS (72934-4023-8)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-4023-8 [72934402308]

BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
MINOXIDIL5 g/100g

Pharmacological Class

  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.